Ad
'Austerity politics mean people in Europe are also facing a growing treatment access gap' (Photo: isobrown)

Why are our medicines so expensive?

In the lead-up to an inter ministerial meeting between EU and India next week, European trade negotiators continue to pressure India and other developing countries to accept so-called “free trade” agreements that favour patent monopolies, high medicines prices, and the interests of the pharmaceutical industry.

Instead, the EU should be promoting open innovation and should work to bring down the prices of essential medicines, both abroad and within its borders.

For Europeans who ha...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Disclaimer

The views expressed in this opinion piece are the author’s, not those of EUobserver

Author Bio

Lisbeth founded EUobserver in 2000 and is responsible to the Board for effective strategic leadership, planning and performance. After graduating from the Danish School of Media and Journalism, she worked as a journalist, analyst, and editor for Danish media.

'Austerity politics mean people in Europe are also facing a growing treatment access gap' (Photo: isobrown)

Tags

Author Bio

Lisbeth founded EUobserver in 2000 and is responsible to the Board for effective strategic leadership, planning and performance. After graduating from the Danish School of Media and Journalism, she worked as a journalist, analyst, and editor for Danish media.

Ad

Related articles

Ad
Ad